Differences in expression of oncogenes and tumor suppressor genes in different sites of head and neck squamous cell

Anticancer Research

Volumn 18, Issue 6 B, 1998, Pages 4793-4800

  Takes, Robert P ^a   De Jong, Robert J Baatenburg ^a   Schuuring, E D ^a   Litvinov, Sergey V ^a   Hermans, J O ^a   Van Krieken, J Han J M ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cell adhesion molecules; Head and neck; Oncogenes; Squamous cell carcinoma

Indexed keywords

CYCLIN D1; DESMOPLAKIN; EPIDERMAL GROWTH FACTOR RECEPTOR; MYC PROTEIN; PROTEIN BCL 2; RETINOBLASTOMA PROTEIN; UVOMORULIN;

ARTICLE; CONTROLLED STUDY; GENE EXPRESSION; HEAD AND NECK CANCER; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LARYNX; LARYNX CARCINOMA; MAJOR CLINICAL STUDY; MOUTH CARCINOMA; MOUTH CAVITY; ONCOGENE; ONCOGENE NEU; PHARYNX; PHARYNX CARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; SQUAMOUS CELL CARCINOMA; TUMOR SUPPRESSOR GENE;

CARCINOMA, SQUAMOUS CELL; GENE EXPRESSION REGULATION, NEOPLASTIC; GENES, TUMOR SUPPRESSOR; HEAD AND NECK NEOPLASMS; HUMANS; IMMUNOHISTOCHEMISTRY; LARYNGEAL NEOPLASMS; MOUTH NEOPLASMS; NEOPLASM PROTEINS; NEOPLASM STAGING; ONCOGENES; PHARYNGEAL NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 0032407336     PISSN: 02507005     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Ahomadegbe JC, Barrois M, Fogel S, Le Bihan ML, Douc-Rasy S, Duvillard P, Armand JP, Riou G: High incidence of p53 alterations (mutation, deletion, overexpression) in head and neck primary tumors and metastases; absence of correlation with clinical outcome. Frequent protein overexpression in. normal epithelium and in early non-invasive lesions. Oncogene 10: 1217-1227; 1995.
2. Andrews NA, Jones AS, Helliwell TR, Kinsella AR: Expression of the E-cadherin-catenin adhesion complex in primary squamous cell carcinomas of the head and neck and their nodal metastases. Br J Cancer 75: 1474-1480, 1997.
3. Baatenburg de Jong RJ, Knegt P, Verwoerd CD: Reduction of the number of neck treatments in patients with head and neck cancer. Cancer 71: 2312-2318, 1993.
4. Bartkova J, Lukas J, Muller H, Strauss M, Gusterson B, Bartek J: Abnormal patterns of D-type cyclin expression and G1 regulation in human head and neck cancer. Cancer Res 55: 949-956, 1995.
5. Batsakis JG: Tumors of the Head and Neck. (Williams and Wilkins) Baltimore, 1979
6. Beckhardt RN, Kiyokawa N, Xi L, Liu T, Hung M, el-Naggar AK, Zhang H, Clayman GL: HER-2/neu oncogene characterization in head and neck cell carcinoma. Arch Otolaryngol Head Neck Surg 121: 1265-1270, 1995.
7. Bowie GL, Caslin AW, Roland NJ, Field JK, Jones AS, Kinsella AR: Expression of the cell-cell adhesion molecule E-cadherin in squamous cell carcinoma of the head and neck. Clin Otolaryngol 18: 196-201, 1993.
8. Christensen ME, Therkildsen MH, Hansen BL, Albeck H, Hansen GN, Bretlau P: Epidermal growth factor receptor expression on oral mucosa dysplastic epithelia and squamous cell carcinomas. Eur Arch Otorhinolaryngol 249: 243-247, 1992.
9. Field JK, Spandidos DA, Malliri A, Gosney JR, Yiagnisis M, Stell PM: Elevated P53 expression correlates with a history of heavy amoking in squamous cell carcinoma of the head and neck. Br J Cancer 64: 573-577, 1991.
10. Field JK, Spandidos DA, Yiagnisis M, Gosney JR, Papadimitriou K, Stell PM: C-erbB-2 expression in squamous cell carcinoma of the head and neck. Anticancer Res 12: 613-619, 1992.
11. Gaffey MJ, Iezzoni JC, Meredith SD, Boyd JC, Stoler MH, Weiss LM, Zukerberg LR, Levine PA, Arnold A, Williams ME: Cyclin D1 (PRAD1, CCND1) and glutathione-S-transferase pi gene expression in head and neck squamous cell carcinoma. Hum Pathol 1995: 1221-1226, 1995.
12. Gan Y, Wientjes MG, Schuller DE, Au JL: Pharmacodynamics of taxol in human head and neck tumors. Cancer Res 56: 2086-2093, 1996.
13. Gapany M, Pavelic ZP, Kelley DJ, Pavelic L, Gapany SR, Craven JM, Stambrook PJ, Gluckman JL: Immunohistochemical detection of c-myc protein in head and neck tumors. Arch Otolaryngol Head Neck. Surg 120: 255-259, 1994.
14. Irish JC, Bernstein A: Oncogenes in head and neck cancer. Laryngoscope 103: 42-52, 1993.
15. Kearsley JH, Leonard JH, Walsh MD, Wright GR: A comparison of epidermal growth factor receptor (EGFR) and c-erbB-2 oncogene expression in head and neck squamous cell carcinomas. Pathology 23: 189-194, 1991.
16. Lavieille JP, Lubin R, Soussi T, Reyt E, Brarnbilla C, Riva C: Analysis of p53 antibody response in patients with squamous cell carcinoma of the head and neck. Anticancer Res 16: 2385-2388, 1996.
17. Lee CS, Redshaw A, Boag G: nm23-H1 protein immunoreactivity in laryngeal carcinoma. Cancer 77: 2246-2250, 1996.